GlaxoSmithKline is a science-led global healthcare company on a mission to help people do more, feel better and live longer. The Company has three world-leading businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products. GlaxoSmithKline manufactures products for major disease areas such as asthma, cancer, infections, diabetes and mental health. 

Company Growth (employees)
Brentford, GB
Size (employees)
99,300 (est)-1%
GlaxoSmithKline was founded in 2001 and is headquartered in Brentford, GB

Key People at GlaxoSmithKline

Andrew Philip Witty

Andrew Philip Witty

Emma Walmsley

Emma Walmsley

CEO of GSK Consumer Healthcare
Simon Dingemans

Simon Dingemans

David Redfern

David Redfern

Dan Troy

Dan Troy

General Counsel
Philip Thomson

Philip Thomson

SVP Global Communications & Government Affairs

GlaxoSmithKline Office Locations

GlaxoSmithKline has offices in Brentford, Tirana, Boudouaou Est, Buenos Aires and in 145 other locations
Brentford, GB (HQ)
980 Great West Road
Wavre, BE
Site Apollo, Pascal Avenue, 2-4-6
Minsk, BY
Office 905, 7a Voronianskogo Street
Bangladesh, IN
Road # 138, Gulshan # 1, Dhaka - 1212
Baku, AZ
96 Nizami Street
Wien, AT
Euro Plaza, Gebäude I, 4. Stock, Wagenseilgasse 3
Show all (149)

GlaxoSmithKline Data and Metrics

GlaxoSmithKline Financial Metrics

GlaxoSmithKline's revenue was reported to be £27.9 b in FY, 2016 which is a 17% increase from the previous period.

Revenue (FY, 2016)

27.9 b

Revenue growth (FY, 2015 - FY, 2016), %


Gross profit (FY, 2016)

18.6 b

Gross profit margin (FY, 2016), %


Net income (FY, 2016)

1.1 b

Market capitalization (25-Jul-2017)

102.5 b

Closing share price (25-Jul-2017)


Cash (31-Dec-2016)

4.9 b
GlaxoSmithKline's current market capitalization is $102.5 b.
GBPFY, 2013FY, 2014FY, 2015FY, 2016


26.5 b23 b23.9 b27.9 b

Revenue growth, %


Cost of goods sold

8.6 b7.3 b8.9 b9.3 b

Gross profit

17.9 b15.7 b15.1 b18.6 b

Gross profit Margin, %


Sales and marketing expense

8.5 b8.2 b9.2 b9.4 b

R&D expense

3.9 b3.5 b3.6 b3.6 b

Operating expense total

10.9 b12.1 b12.8 b13 b

Interest expense

767 m727 m757 m736 m

Interest income

104 m68 m104 m72 m

Pre tax profit

6.6 b3 b10.5 b1.9 b

Income tax expense

1 b137 m2.2 b877 m

Net Income

5.6 b2.8 b8.4 b1.1 b
GBPFY, 2013FY, 2014FY, 2015FY, 2016


5.5 b4.3 b5.8 b4.9 b

Accounts Receivable

4 b3.6 b3.9 b4.7 b

Current Assets

15.2 b14.7 b16.6 b16.7 b


13.4 b13.9 b15 b17.6 b


13.5 b12 b21.8 b24.7 b

Total Assets

42.1 b40.7 b53.4 b59.1 b

Accounts Payable

2.7 b2.8 b3.1 b3.6 b

Current Liabilities

13.7 b13.3 b13.4 b19 b

Total Liabilities

35.1 b36.4 b48.3 b58 b

Retained Earnings

1.9 b(1.1 b)4.6 b(3.9 b)

Total Equity

7 b4.3 b5.1 b1.1 b

Financial Leverage

6 x9.5 x10.5 x52.6 x
GBPFY, 2013FY, 2014FY, 2015FY, 2016

Cash From Operating Activities

2.6 b5.2 b7.2 b6.5 b

Cash From Financing Activities

(6.3 b)(5.4 b)(7.1 b)(6.4 b)

Income Taxes Paid

(1 b)(137 m)(2.2 b)(877 m)
Y, 2016

Financial Leverage

52.6 x

GlaxoSmithKline Operating Metrics

GlaxoSmithKline's Unique Visitors was reported to be 1.8 m in FY, 2016
FY, 2015FY, 2016FY, 2017



Manufacturing Facilities




New Product Launches



1.5 k1.5 k

Unique Visitors

1.8 m

    GlaxoSmithKline Market Value History

    GlaxoSmithKline Revenue Breakdown

    GlaxoSmithKline Median Salaries

    Source: 173 public H-1B filings from GlaxoSmithKline

    Traffic Overview of GlaxoSmithKline

    GlaxoSmithKline Online and Social Media Presence

    GlaxoSmithKline Company Life and Culture

    You may also be interested in